The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shchelokova E.E.

Sechenov First Moscow State Medical University

Kogan E.A.

Sechenov First Moscow State Medical University

Avraamova S.T.

Sechenov First Moscow State Medical University

Demura T.A.

Sechenov First Moscow State Medical University

Zharkov N.V.

Sechenov First Moscow State Medical University

Kovyazina N.V.

The Russian University of Medicine (RosUniMed)

Mordovina A.I.

Sechenov First Moscow State Medical University (Sechenov University)

Zelenchenkova P.I.

Sechenov First Moscow State Medical University (Sechenov University)

Meerovich G.A.

Sechenov First Moscow State Medical University;
A.M. Prokhorov General Physics Institute Russian Academy of Sciences

Reshetov I.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia

Features of lung cancer carcinogenesis involving cancer stem cells in COVID-19. Effects of photodynamic therapy in the treatment of cancer and COVID-19

Authors:

Shchelokova E.E., Kogan E.A., Avraamova S.T., Demura T.A., Zharkov N.V., Kovyazina N.V., Mordovina A.I., Zelenchenkova P.I., Meerovich G.A., Reshetov I.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2025;87(5): 65‑73

DOI: 10.17116/patol20258705165

Read: 576 times

Download PDF (RU)
Contact the author
Table of contents

FEATURES OF LUNG CANCER CARCINOGENESIS INVOLVING CANCER STEM CELLS IN COVID-19. EFFECTS OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF CANCER AND COVID-19
FEATURES OF LUNG CANCER CARCINOGENESIS INVOLVING CANCER STEM CELLS IN COVID-19. EFFECTS OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF CANCER AND COVID-19

To cite this article:

Shchelokova EE, Kogan EA, Avraamova ST, et al. . Features of lung cancer carcinogenesis involving cancer stem cells in COVID-19. Effects of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;87(5):65‑73. (In Russ.)
https://doi.org/10.17116/patol20258705165

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Lapa­roscopic appe­ndectomy for appe­ndiceal muco­cele in a patient with COVID-19. Endo­scopic Surgery. 2024;(6):41-45
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
Sele­ctive anosmia for mono­molecular odorants in a cohort of young indi­viduals. Russian Rhinology. 2024;(4):262-268
The resu­lts of the examination of patients with chro­nic gene­ralized periodontitis after novel coro­navirus infe­ction. Russian Journal of Stomatology. 2024;(4):18-22
Modern possibilities of using photodynamic therapy with an intravenous sensitizer as an alte­rnative to surgical treatment: a clinical case of successful. Russian Journal of Human Reproduction. 2024;(6):149-155
Waiting for Disease X: a plan for preparing Russian labo­ratory services for the next pandemic. Labo­ratory Service. 2024;(4):5-11
Photodynamic inactivation of anti­biotic-resistant microflora of gunshot wounds under fluorescence control. Piro­gov Russian Journal of Surgery. 2025;(2):50-59
Abstract:

Lung cancer occupies a leading position among malignant neoplasms throughout the world, and the issue of carcinogenesis of this disease today still remains relevant. This review examines in detail the issue of the participation of cancer stem cells in the development of lung cancer, the concept of the stem cell niche, and options for their detection using molecular and immunohistochemical studies. A separate section examines the impact of the new coronavirus infection COVID-19 on CSC and lung cancer carcinogenesis in general, as well as the successful results of the use of photodynamic therapy in the treatment of both diseases.

Keywords:

cancer stem cell
lung cancer
COVID-19
photodynamic therapy

Authors:

Shchelokova E.E.

Sechenov First Moscow State Medical University

Kogan E.A.

Sechenov First Moscow State Medical University

Avraamova S.T.

Sechenov First Moscow State Medical University

Demura T.A.

Sechenov First Moscow State Medical University

Zharkov N.V.

Sechenov First Moscow State Medical University

Kovyazina N.V.

The Russian University of Medicine (RosUniMed)

Mordovina A.I.

Sechenov First Moscow State Medical University (Sechenov University)

Zelenchenkova P.I.

Sechenov First Moscow State Medical University (Sechenov University)

Meerovich G.A.

Sechenov First Moscow State Medical University;
A.M. Prokhorov General Physics Institute Russian Academy of Sciences

Reshetov I.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Health of Russia

Received:

11.04.2025

Accepted:

25.06.2025

Close metadata

References:

  1. Bray F, Laversanne M, Sung H et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.  https://doi.org/10.3322/caac.21834
  2. Zhang Y, Vaccarella S, Morgan E et al. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023;24(11):1206-1218. https://doi.org/10.1016/S1470-2045(23)00444-8
  3. Kogan EA, Meerovich GA, Karshieva SSh et al. Cancer stem cell as a target for photodynamic therapy of lung cancer. In: Abrikosov Readings: Proceedings of the Scientific-Practical Conference, Moscow, May 19—20, 2023. Moscow: Prakticheskaya Meditsina. 2023:50-51. (In Russ.)
  4. Sampayo RG, Bissell MJ. Cancer stem cells in breast and prostate: Fact or fiction? Adv Cancer Res. 2019;144:315-341.  https://doi.org/10.1016/bs.acr.2019.03.010
  5. Manfioletti G, Fedele M. Epithelial-Mesenchymal Transition (EMT). Int J Mol Sci. 2023;24(14):11386. https://doi.org/10.3390/ijms241411386
  6. Fukazawa T, Guo M., Ishida N et al. Sox2 Suppresses Cdkn1a to Sustain Growth of Lung Squamous Cell Carcinoma. Sci Rep. 2016;6:20113. https://doi.org/10.1038/srep20113
  7. Huang T, Song X, Xu D et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10(19): 8721-8743. https://doi.org/10.7150/thno.41648
  8. He Y, Jiang X, Duan L et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. Mol Cancer. 2021;20(1):156.  https://doi.org/10.1186/s12943-021-01469-6
  9. Xie C, Zhu J, Jiang Y et al. Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties via the IL-6/ΔNp63α/Notch Axis. Theranostics. 2019;9(16):4827-4840. https://doi.org/10.7150/thno.33812
  10. Jin Y., Chen Y, Tang H et al. Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer. Clin Cancer Res. 2022;28(3):526-539.  https://doi.org/10.1158/1078-0432.CCR-21-1943
  11. Wang Y, Liu F, Chen L et al. Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway. Front Immunol. 2022;13:867516. https://doi.org/10.3389/fimmu.2022.867516
  12. Mohan A, Raj Rajan R, Mohan G et al. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells. Front Cell Dev Biol. 2021;9:668851. https://doi.org/10.3389/fcell.2021.668851
  13. Tomita H, Tanaka K, Tanaka T., Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7(10):11018-11032. https://doi.org/10.18632/oncotarget.6920
  14. Mohan A, Raj Rajan R, Mohan G et al. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells. Front Cell Dev Biol. 2021;9:668851. https://doi.org/10.3389/fcell.2021.668851
  15. Gzil A, Zarebska I, Bursiewicz W et al. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications. Mol Biol Rep. 2019;46(6):6629-6645. https://doi.org/10.1007/s11033-019-05058-1
  16. Liu S, Cheng K, Zhang H et al. Methylation Status of the Nanog Promoter Determines the Switch Between Cancer Cells and Cancer Stem Cells. Adv Sci (Weinh). 2020;7(5):1903035. https://doi.org/10.1002/advs.201903035
  17. Plaks V, Kong N, Werb Z. The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells? Cell Stem Cell. 2015;16(3):225-238.  https://doi.org/10.1016/j.stem.2015.02.015
  18. Cabrera MC, Hollingsworth RE., Hurt EM. Cancer Stem Cell Plasticity and Tumor Hierarchy. World J Stem Cells. 2015;7(1):27-36.  https://doi.org/10.4252/wjsc.v7.i1.27
  19. Andriani F, Majorini MT, Mano M et al. MiR-16 Regulates the Pro-Tumorigenic Potential of Lung Fibroblasts Through the Inhibition of HGF Production in an FGFR-1- and MEK1-Dependent Manner. J Hematol Oncol. 2018;11:1-12.  https://doi.org/10.1186/s13045-018-0594-4
  20. Wang L, Cao L, Wang H et al. Cancer-Associated Fibroblasts Enhance Metastatic Potential of Lung Cancer Cells Through IL-6/STAT3 Signaling Pathway. Oncotarget. 2017;8(44):76116-76128. https://doi.org/10.18632/oncotarget.18814
  21. Costa BA, da Luz KV., Campos SEV et al. Can SARS-CoV-2 Induce Hematologic Malignancies in Predisposed Individuals? A Case Series and Review of the Literature. Hematol Transfus Cell Ther. 2022;44(1):26-31.  https://doi.org/10.1016/j.htct.2021.11.015
  22. Kogan EA, Kichigina ON, Zachariah Atir. Morphological Manifestations of Lung Pathology in Post-COVID Syndrome According to Autopsy Results for 2021—2023. Bulletin of NovSU. 2024;4(138):552-562. (In Russ.) https://doi.org/10.34680/2076-8052.2024.4(138).552-562
  23. Gregory TA., Knight SR, Aaroe AE et al. Accelerated Tumor Progression After COVID-19 Infection in Patients With Glioblastoma: A Retrospective Case-Control Study. Neurooncol Pract. 2024;11(4):475-483.  https://doi.org/10.1093/nop/npae029
  24. Becker S, Jonigk D, Luft A et al. COVID-19 Can Lead to Rapid Progression of Cervical Intraepithelial Neoplasia by Dysregulating the Immune System: A Hypothesis. J Reprod Immunol. 2022;154:103763. https://doi.org/10.1016/j.jri.2022.103763
  25. Kawamoto H, Saito-Sasaki N, Sawada Y. Recurrent Merkel Cell Carcinoma Following COVID-19 Treatment. Cureus. 2024;16(7): e64863. https://doi.org/10.7759/cureus.64863
  26. Chua TH, Punjabi LS, Khor LY. Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology. Pathogens. 2021;10(11):1410. https://doi.org/10.3390/pathogens10111410
  27. Kogan EA, Shchelokova EE, Demura TA et al. ALDH1-, CD133-, CD34-Positive Cancer Stem Cells in Lung Adenocarcinoma of Patients After SARS-CoV-2 Infection. Russian Journal of Archive of Pathology. 2024;86(5):5-14. (In Russ.) https://doi.org/10.17116/patol2024860515
  28. Fenizia C, Galbiati S, Vanetti C et al. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells. 2021;10(6):1434. https://doi.org/10.3390/cells10061434
  29. Chu X, Tian W, Ning J et al. Cancer Stem Cells: Advances in Knowledge and Implications for Cancer Therapy. Signal Transduct Target Ther. 2024;9:170.  https://doi.org/10.1038/s41392-024-01851-y
  30. Espinosa-Sánchez A, Suárez-Martínez E, Sánchez-Díaz L, Carnero A. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Front Oncol. 2020;10:1533. https://doi.org/10.3389/fonc.2020.01533
  31. Wang K, Chen W, Zhang Z et al. CD147-Spike Protein Is a Novel Route for SARS-CoV-2 Infection to Host Cells. Signal Transduct Target Ther. 2020;5(1):283.  https://doi.org/10.1038/s41392-020-00426-x
  32. Nyalali AMK., Leonard AU, Xu Y et al. CD147: An Integral and Potential Molecule to Abrogate Hallmarks of Cancer. Front Oncol. 2023;13:1238051. https://doi.org/10.3389/fonc.2023.1238051
  33. Sienel W, Mecklenburg I, Dango S et al. Cellular Localization of EMMPRIN Predicts Prognosis of Patients With Operable Lung Adenocarcinoma Independent From MMP-2 and MMP-9. Mod Pathol. 2008;21(9):1130-1138. https://doi.org/10.1038/modpathol.2008.105
  34. Huang Z, Meng S, Wang L et al. Suppression of oxLDL-Induced MMP-9 and EMMPRIN Expression by Berberine via Inhibition of NF-κB Activation in Human THP-1 Macrophages. Anat Rec (Hoboken). 2012;295(1):78-86.  https://doi.org/10.1002/ar.21489
  35. Zhang N, Liu Z, Lai X et al. Silencing of CD147 Inhibits Cell Proliferation, Migration, Invasion, Lipid Metabolism Dysregulation and Promotes Apoptosis in Lung Adenocarcinoma via Blocking the Rap1 Signaling Pathway. Respir Res. 2023;24(1):253.  https://doi.org/10.1186/s12931-023-02532-0
  36. Granja S, Marchiq I, Le Floch R et al. Disruption of BASIGIN Decreases Lactic Acid Export and Sensitizes Non-Small Cell Lung Cancer to Biguanides Independently of the LKB1 Status. Oncotarget. 2015;6(9):6708-6721. https://doi.org/10.18632/oncotarget.2862
  37. Wang C, Xu C, Niu R et al. MiR-890 Inhibits Proliferation and Invasion and Induces Apoptosis in Triple-Negative Breast Cancer Cells by Targeting CD147. BMC Cancer. 2019;19(1):577.  https://doi.org/10.1186/s12885-019-5796-9
  38. Dai L, Guinea M.C, Slomiany MG. et al. CD147-Dependent Heterogeneity in Malignant and Chemoresistant Properties of Cancer Cells. Am J Pathol. 2013;182(2):577-585.  https://doi.org/10.1016/j.ajpath.2012.10.018
  39. Liu B, Wan Z, Sheng B et al. Overexpression of EMMPRIN Is Associated With Lymph Node Metastasis and Advanced Stage of Non-Small Cell Lung Cancer. BMC Pulm Med. 2017;17:214.  https://doi.org/10.1186/s12890-017-0540-1
  40. Tanzadehpanah H, Lotfian E, Avan A et al. Role of SARS-COV-2 and ACE2 in the Pathophysiology of Peripheral Vascular Diseases. Biomed Pharmacother. 2023;166:115321. https://doi.org/10.1016/j.biopha.2023.115321
  41. Delpino MV, Quarleri J. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Front Cell Infect Microbiol. 2020;10:340.  https://doi.org/10.3389/fcimb.2020.00340
  42. Hirano T, Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020;52(5): 731-733.  https://doi.org/10.1016/j.immuni.2020.04.003
  43. Okudela K, Woo T, Mitsui H. et al. Expression of the Potential Cancer Stem Cell Markers, CD133, CD44, ALDH1, and β-Catenin, in Primary Lung Adenocarcinoma — Their Prognostic Significance. Pathol Int. 2012;62(12):792-801.  https://doi.org/10.1111/pin.12019
  44. Tajti G, Gebetsberger L, Pamlitschka G et al. Cyclophilin – CD147 Interaction Enables SARS-CoV-2 Infection of Human Monocytes and Their Activation via Toll-Like Receptors 7 and 8. Front Immunol. 2025;16:1460089. https://doi.org/10.3389/fimmu.2025.1460089
  45. Wang K, Chen W, Zhang Z. et al. CD147-Spike Protein Is a Novel Route for SARS-CoV-2 Infection to Host Cells. Signal Transduct Target Ther. 2020;5(1):283.  https://doi.org/10.1038/s41392-020-00426-x
  46. Shouman S, El-Kholy N, Hussien AE et al. SARS-CoV-2-Associated Lymphopenia: Possible Mechanisms and the Role of CD147. Cell Commun Signal. 2024;22:349.  https://doi.org/10.1186/s12964-024-01718-3
  47. Mehta P, McAuley DF, Brown M et al. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020;395(10229):1033-1034. https://doi.org/10.1016/S0140-6736(20)30628-0
  48. Ferguson LP., Diaz E, Reya T. The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer. Trends Cancer. 2021;7(7):624-634.  https://doi.org/10.1016/j.trecan.2021.03.003
  49. Xu F, Wei Y, Tang Z et al. Tumor-Associated Macrophages in Lung Cancer: Friend or Foe? Mol Med Rep. 2020;22(5):4107-4115. https://doi.org/10.3892/mmr.2020.11518
  50. Meacham CE, Morrison SJ. Tumour Heterogeneity and Cancer Cell Plasticity. Nature. 2013;501(7467):328-337.  https://doi.org/10.1038/nature12624
  51. Lee HJ, Park MK., Lee EJ., Lee CH. Resolvin D1 Inhibits TGF-β1-Induced Epithelial Mesenchymal Transition of A549 Lung Cancer Cells via Lipoxin A4 Receptor/Formyl Peptide Receptor 2 and GPR32. Int J Biochem Cell Biol. 2013;45(12):2801-2807. https://doi.org/10.1016/j.biocel.2013.09.018
  52. Wang R, Zhang J, Chen S et al. Tumor-Associated Macrophages Provide a Suitable Microenvironment for Non-Small Lung Cancer Invasion and Progression. Lung Cancer. 2011;74(2):188-196.  https://doi.org/10.1016/j.lungcan.2011.04.009
  53. Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP Modulator in Cancer, Development and Tissue Repair. Biochimie. 2005;87(3-4):361-368.  https://doi.org/10.1016/j.biochi.2004.09.023
  54. Fei F, Li X, Xu L et al. CD147-CD98hc Complex Contributes to Poor Prognosis of Non-Small Cell Lung Cancer Patients Through Promoting Cell Proliferation via the PI3K/Akt Signaling Pathway. Ann Surg Oncol. 2014;21(13):4359-4368. https://doi.org/10.1245/s10434-014-3816-1
  55. Bakhtiyari M, Haji Aghasi A, Banihashemi S et al. CD147 and Cyclophilin A: A Promising Potential Targeted Therapy for COVID-19 and Associated Cancer Progression and Chemo-Resistance. Infect Agents Cancer. 2023;18:20.  https://doi.org/10.1186/s13027-023-00501-2
  56. Jaiswal A, Shrivastav S, Kushwaha HR et al. Oncogenic Potential of SARS-CoV-2—Targeting Hallmarks of Cancer. Cell Commun Signal. 2024;22:447.  https://doi.org/10.1186/s12964-024-01818-0
  57. Wang CH., Yao H, Chen LN et al. CD147 Induces Angiogenesis Through a Vascular Endothelial Growth Factor and Hypoxia-Inducible Transcription Factor 1a-Mediated Pathway in Rheumatoid Arthritis. Arthritis Rheumatol. 2012;64(6):1818-1827. https://doi.org/10.1002/art.34341
  58. Krock BL, Skuli N, Simon MC. Hypoxia-Induced Angiogenesis: Good and Evil. Genes Cancer. 2011;2(12):1117-1133. https://doi.org/10.1177/1947601911423654
  59. Lan J, Ge J, Yu J et al. Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor. Nature. 2020;581(7807):215-220.  https://doi.org/10.1038/s41586-020-2180-5
  60. Demura SA, Kogan EA, Goryachkina VL. Chronic Diseases, Precancer and Lung Cancer Associated With Pathology of Club Cells in Respiratory and Terminal Bronchioles. Russian Journal of Archive of Pathology. 2018;80(5):63-68. (In Russ.) https://doi.org/10.17116/patol20188005163
  61. Blagova OV, Kogan E.A, Lutokhina YuA et al. COVID-19 in Patients With Primary Cardiomyopathies: Role of Post-COVID Myocarditis. Clin Exp Surg. Petrovsky J. 2024;12(2):71-80. (In Russ.) https://doi.org/10.33029/2308-1198-2024-12-2-71-80
  62. Jaiswal A, Shrivastav S, Kushwaha HR et al. Oncogenic Potential of SARS-CoV-2—Targeting Hallmarks of Cancer Pathways. Cell Commun Signal. 2024;22:447.  https://doi.org/10.1186/s12964-024-01818-0
  63. Ogarek N, Oboza P, Olszanecka-Glinianowicz M et al. SARS-CoV-2 Infection as a Potential Risk Factor for the Development of Cancer. Front Mol Biosci. 2023;10:1260776. https://doi.org/10.3389/fmolb.2023.1260776
  64. Liapis I, Baritaki S COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones Within an Inflamed Microenvironment. Cancers (Basel). 2022;14(17):4330. https://doi.org/10.3390/cancers14174330
  65. Mfouo-Tynga IS, Mouinga-Ondeme AG. Photodynamic Therapy: A Prospective Therapeutic Approach for Viral Infections and Induced Neoplasia. Pharmaceuticals (Basel). 2022;15(10):1273. https://doi.org/10.3390/ph15101273
  66. Crous A, Kumar SSD, Abrahamse H. Effect of Dose Responses of Hydrophilic Aluminium (III) Phthalocyanine Chloride Tetrasulphonate Based Photosensitizer on Lung Cancer Cells. J Photochem Photobiol B. 2019;194:96-106.  https://doi.org/10.1016/j.jphotobiol.2019.03.018
  67. Kogan EA, Meerovich GA, Karshieva SSh et al. Polycationic Photosensitizers as Targeted Therapy Agents for Lung Cancer. Photonics. 2024;11(6):485.  https://doi.org/10.3390/photonics11060485
  68. Emadi E, Hamidi Alamdari D, Attaran D et al. Application of Methylene Blue for the Prevention and Treatment of COVID-19. Iran J Basic Med Sci. 2024;27(7):780-792.  https://doi.org/10.22038/IJBMS.2024.71871.15617
  69. Crous A, Abrahamse H. Aluminium (III) Phthalocyanine Chloride Tetrasulphonate Is an Effective Photosensitizer for the Eradication of Lung Cancer Stem Cells. R Soc Open Sci. 2021;8(5):210148. https://doi.org/10.1098/rsos.210148
  70. Svyatchenko VA, Nikonov SD, Mayorov AP et al. Antiviral Photodynamic Therapy: Inactivation and Inhibition of SARS-CoV-2 In Vitro Using Methylene Blue and Radachlorin. Photodiagnosis Photodyn Ther. 2021;33:102112. https://doi.org/10.1016/j.pdpdt.2020.102112
  71. Cagno V, Medaglia C, Cerny A. et al. Methylene Blue Has a Potent Antiviral Activity Against SARS-CoV-2 and H1N1 Influenza Virus In Vitro. Sci Rep. 2021;11(1):14295. https://doi.org/10.1038/s41598-021-92481-9
  72. Zhukhovitsky V, Shevlyagina N, Zubasheva M et al. Infectivity and Morphology of Bovine Coronavirus Inactivated In Vitro by Cationic Photosensitizers. Viruses. 2022;14(5):1053. https://doi.org/10.3390/v14051053
  73. Sharshov K, Solomatina M, Kurskaya O et al. The Photosensitizer Octakis(cholinyl)zinc Phthalocyanine With Ability to Bind to a Model Spike Protein Leads to a Loss of SARS-CoV-2 Infectivity In Vitro When Exposed to Far-Red LED. Viruses. 2021;13(4):643.  https://doi.org/10.3390/v13040643
  74. Shafirstein G, Battoo A, Harris K et al. Photodynamic Therapy of Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2016;13(2): 265-275.  https://doi.org/10.1513/AnnalsATS.201509-650FR
  75. Reshetov IV, Shiryaev AA, Loschenov VB et al. COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy. ClinicalTrials.gov. 2021. ID: NCT04933864. https://clinicaltrials.gov/study/NCT04933864
  76. Jaiswal A, Shrivastav S, Kushwaha HR et al. Oncogenic Potential of SARS-CoV-2—Targeting Hallmarks of Cancer Pathways. Cell Commun Signal. 2024;22:447.  https://doi.org/10.1186/s12964-024-01818-0
  77. Ogarek N, Oboza ., Olszanecka-Glinianowicz M et al. SARS-CoV-2 Infection as a Potential Risk Factor for the Development of Cancer. Front Mol Biosci. 2023;10:1260776. https://doi.org/10.3389/fmolb.2023.1260776
  78. Liapis I, Baritaki S. COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones Within an Inflamed Microenvironment. Cancers (Basel). 2022;14(17):4330. https://doi.org/10.3390/cancers14174330
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.